Sensely, a San Francisco, CA-based virtual medical assistant application for patient engagement and chronic disease monitoring, completed an $8m Series B financing.
The round was led by Chengwei Capital with participation from Bioveda Ventures, Fenox Venture Capital, Mayo Clinic, and Stanford StartX.
The company intends to use the funds to expand its presence in the US, UK, and international markets.
Led by founder and CEO Adam Odessky, Sensely offers a patient engagement solution that provides proven primary care access, chronic disease monitoring and follow-up care. The virtual medical assistant combines innovative avatar-based technology, advanced sensor capabilities, and telemedicine features that generate actionable, real-time data and intelligent analytics.